ArticlePharmacoEconomics2025

Correction: De Novo Cost‑Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation.

Peter Gal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.